| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and COO | President and CEO
4 companies
Daniel N Swisher Jr. is President and CEO at VIRX and has filed Form 4s across 4 companies. From February 2015 to October 2025, the filings on record show 5 open-market purchases and 39 sales. Daniel N Swisher Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.1M at current prices.
Historically, Daniel N Swisher Jr.'s trades have earned a below-average insider score of 48/100 across 35 rated trades. Over a 12-month horizon, 27.3% of those trades were profitable, with an average 12-month return of -35.3%.
The biggest single holding is JAZZ (~$12.6M) as President and COO.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $59.46 | $130,812.00 | - | -4.1% | +45.1% | |
| Nov 11, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $59.88 | $131,736.00 | - | +14.4% | +33.8% | |
| Aug 1, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 150 | $38.50 | $5,775.00 | - | +23.6% | +81.9% | |
| Jul 1, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $32.81 | $72,182.00 | - | +41.7% | +112.2% | |
| Jun 3, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $30.21 | $66,462.00 | - | +9.5% | +122.1% | |
| May 9, 2024 | CERS Cerus Corp | Director | Buy | 2,500 | $1.88 | $4,688.75 | +2.4% | +9.4% | -32.5% | |
| May 1, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $23.09 | $50,798.00 | - | +51.3% | +199.3% | |
| Apr 1, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $25.30 | $55,660.00 | - | +26.9% | +257.1% | |
| Mar 1, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $23.59 | $51,898.00 | - | +29.7% | +151.8% | |
| Feb 1, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $22.00 | $48,400.00 | - | +10.4% | +209.4% |